Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Na Huang
Institutions:
Guangdong Medical College,
Ningxia University
Observed institutions:
Guangdong Medical College,
Ningxia University,
Nanfang Hospital,
Second Affiliated Hospital of Xi'an Jiaotong University,
Southern Medical University,
Xi'an Jiaotong University
show all 6
ORCID:
0000-0001-7961-0677
Observed ORCID:
0000-0001-7961-0677
OpenAlex ID:
A5006459894
Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2023
·
Yannan Zheng
, Rui Zhou
, et al.
·
Cancer Research
·
103
PDF
Intratumoral and peritumoral PET/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC
2025
·
Xianwen Lin
, Zhiwei Liu
, et al.
·
British Journal of Cancer
·
43
PDF
Influence of experimental variables on spheroid attributes
2025
·
Songshan Zhu
, Jun Yin
, et al.
·
Scientific Reports
·
39
Pancreatic Adverse Events Associated With Immune Checkpoint Inhibitors: A Large-Scale Pharmacovigilance Analysis
2022
·
Yue Zhang
, Yisheng Fang
, et al.
·
Frontiers in Pharmacology
·
22
PDF
TCR-T cell therapy for solid tumors: challenges and emerging solutions
2025
·
Wanjun He
, Kai Cui
, et al.
·
Frontiers in Pharmacology
·
18
Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer
2025
·
Dongqiang Zeng
, Yunfang Yu
, et al.
·
Advanced Science
·
17
A combined model of serum neutrophil extracellular traps, CD 8 + T cells, and tumor proportion score provides better prediction of PD ‐1 inhibitor efficacy in patients with NSCLC
2024
·
Jian Guo
, Tingting Shu
, et al.
·
FEBS Journal
·
16
PDF
Genetic and microenvironmental evolution of colorectal liver metastases under chemotherapy
2024
·
Min Shi
, Yingxi Yang
, et al.
·
Cell Reports Medicine
·
15
Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation
2025
·
Fei Sun
, Fangzhen Yao
, et al.
·
Journal for ImmunoTherapy of Cancer
·
14
Residual tumor cells after insufficient radiofrequency ablation promote lung metastasis by educating CD177hiPAD4hi neutrophils
2025
·
Na Huang
, Yisheng Fang
, et al.
·
Nature Communications
·
5
Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancer
2025
·
Nan Huang
, Nan Huang
, et al.
·
Autophagy
·
5
Mechanical Force‐Induced cGAS Activation in Carcinoma Cells Facilitates Splenocytes into Liver to Drive Metastasis
2024
·
Xurui Zhang
, Na Huang
, et al.
·
Advanced Science
·
5
Heparanase‐Loaded CAR T Extracellular Vesicles Remodel the Colorectal Tumour Microenvironment and Boost T Cell Antitumor Immunity
2026
·
Songshan Zhu
, Jun Yin
, et al.
·
Journal of Extracellular Vesicles
·
4
The challenges and progress of CAR-T cell therapy in the treatment of solid tumors
2025
·
Kai Cui
, Wanjun He
, et al.
·
Molecular and Cellular Biochemistry
·
3
Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors
2026
·
Iqra Ajmal
, Bingtan Du
, et al.
·
Frontiers in Immunology
·
2
Overexpression of HIF-1α via small activating RNA enhances CAR-T cell function in hypoxic microenvironments
2026
·
Na Huang
, Qi Chen
, et al.
·
Pharmacological Research
·
2
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials
2025
·
Zhaojun Wang
, Yiran Fang
, et al.
·
Advanced Science
·
1
Dynamic single‐cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapy
2024
·
Qianqian Mao
, Zhenzhen Wu
, et al.
·
Cancer Science
·
1
Supplementary Methods from Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2023
·
Yannan Zheng
, Rui Zhou
, et al.
·
1
Tumor microenvironment evaluation to predict anti–PD-1 response of advanced gastric cancer: Results from a multicenter prospective clinical trial.
2023
·
Wangjun Liao
, Min Shi
, et al.
·
Journal of Clinical Oncology
·
1
Figure S7 from Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2025
·
Yannan Zheng
, Rui Zhou
, et al.
PDF
Table S3 from Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2025
·
Yannan Zheng
, Rui Zhou
, et al.
Figure S4 from Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2025
·
Yannan Zheng
, Rui Zhou
, et al.
PDF
Figure S2 from Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2025
·
Yannan Zheng
, Rui Zhou
, et al.
PDF
Figure S3 from Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
2025
·
Yannan Zheng
, Rui Zhou
, et al.
Show more works
View as search
Works count:
63
Citation count:
338
H-index:
10
I10-index:
10
Year
Topic
Type